Loading...
XNYSAVD
Market cap144mUSD
Jan 16, Last price  
5.02USD
1D
2.24%
1Q
-8.06%
Jan 2017
-73.79%
Name

American Vanguard Corp

Chart & Performance

D1W1MN
XNYS:AVD chart
P/E
19.22
P/S
0.25
EPS
0.26
Div Yield, %
2.34%
Shrs. gr., 5y
-1.03%
Rev. gr., 5y
4.99%
Revenues
579m
-4.96%
150,855,000189,796,000193,771,000216,662,000237,538,000209,329,000229,620,000304,429,000366,190,000381,021,000298,634,000289,382,000312,113,000355,047,000454,272,000468,186,000458,704,000556,872,000609,615,000579,371,000
Net income
8m
-72.56%
14,477,00019,002,00015,448,00018,728,00020,019,000-5,789,00010,984,00022,068,00036,867,00034,449,0004,841,0006,591,00012,788,00020,274,00024,195,00013,601,00015,242,00018,587,00027,404,0007,519,000
CFO
-59m
L
15,410,00018,749,000-29,817,00055,507,0003,073,00031,951,00033,190,00039,266,00040,424,000-6,214,000-34,095,00078,568,00046,406,00059,001,00011,346,0009,403,00089,197,00087,318,00057,105,000-58,748,000
Dividend
Jun 26, 20240.03 USD/sh
Earnings
Mar 12, 2025

Profile

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, soil health, plant nutrition, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. The company also markets, sells, and distributes end-use chemical and biological products for crop applications; and distributes chemicals for turf and ornamental markets. It distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. The company was incorporated in 1969 and is headquartered in Newport Beach, California.
IPO date
Mar 03, 1987
Employees
822
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
579,371
-4.96%
609,615
9.47%
Cost of revenue
556,076
555,011
Unusual Expense (Income)
NOPBT
23,295
54,604
NOPBT Margin
4.02%
8.96%
Operating Taxes
2,778
8,561
Tax Rate
11.93%
15.68%
NOPAT
20,517
46,043
Net income
7,519
-72.56%
27,404
47.44%
Dividends
(3,384)
(2,787)
Dividend yield
1.08%
0.43%
Proceeds from repurchase of equity
(17,506)
(34,405)
BB yield
5.59%
5.31%
Debt
Debt current
12,162
5,279
Long-term debt
179,207
95,740
Deferred revenue
Other long-term liabilities
3,138
4,167
Net debt
179,953
77,807
Cash flow
Cash from operating activities
(58,748)
57,105
CAPEX
(12,064)
(14,554)
Cash from investing activities
(17,017)
(14,470)
Cash from financing activities
66,737
(38,260)
FCF
(88,325)
43,174
Balance
Cash
11,416
20,328
Long term investments
2,884
Excess cash
Stockholders' equity
330,401
320,007
Invested Capital
547,404
450,394
ROIC
4.11%
10.19%
ROCE
4.20%
11.74%
EV
Common stock shares outstanding
28,533
29,872
Price
10.97
-49.47%
21.71
32.46%
Market cap
313,007
-51.74%
648,521
30.12%
EV
492,960
726,328
EBITDA
46,829
76,742
EV/EBITDA
10.53
9.46
Interest
13,007
3,954
Interest/NOPBT
55.84%
7.24%